Snail2 promotes osteosarcoma cell motility through remodelling of the actin cytoskeleton and regulates tumor development

Cancer Letters

Volumn 333, Issue 2, 2013, Pages 170-179

  Sharili, Amir Shaya ^a,c   Allen, Steve ^a   Smith, Ken ^a   Price, Joanna ^b   McGonnell, Imelda M ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Actin cytoskeleton; Invasion; Migration; Osteosarcoma; Snail2; Tumorigenesis

Indexed keywords

ACTIN; CADHERIN; CELL ADHESION MOLECULE; OB CADHERIN; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR SNAIL 2; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CELL MIGRATION; CELL MOTILITY; CELL STRUCTURE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; CYTOSKELETON; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; NONHUMAN; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ACTIN CYTOSKELETON; ANIMALS; BONE NEOPLASMS; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; CHICK EMBRYO; FOCAL ADHESIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MEMBRANE PROTEINS; OSTEOSARCOMA; PROTO-ONCOGENE PROTEINS; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; WNT PROTEINS;

EID: 84876727688     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.01.027     Document Type: Article

References (43)

1. Alves C.C., Carneiro F., Hoefler H., Becker K.F. Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers. Frontiers in Bioscience 2009, 14:3035-3050.
2. Nieto M.A. The snail superfamily of zinc-finger transcription factors. Nature Reviews Molecular Cell Biology 2002, 3:155-166.
3. Hajra K.M., Chen D.Y., Fearon E.R. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Research 2002, 62:1613-1618.
4. Bolos V., Peinado H., Perez-Moreno M.A., et al. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. Journal of Cell Science 2003, 116:499-511.
5. Xu J., Lamouille S., Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell Research 2009, 19:156-172.
6. Oram K.F., Carver E.A., Gridley T. Slug expression during organogenesis in mice. Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology 2003, 271:189-191.
7. Sharili A.S., Allen S., Smith K., Hargreaves J., Price J., McGonnell I. Expression of Snail2 in long bone osteosarcomas correlates with tumour malignancy. Tumour Biology 2011, 32:515-526.
8. Park S.H., Cheung L.W., Wong A.S., Leung P.C. Estrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha. Molecular Endocrinology 2008, 22:2085-2098.
9. Blakely B.D., Bye C.R., Fernando C.V., et al. Wnt5a regulates midbrain dopaminergic axon growth and guidance. PLoS ONE 2011, 6:e18373.
10. Hamburger V., Hamilton H.L. A series of normal stages in the development of the chick embryo. Developmental Dynamics 1951, 195(1992):231-272.
11. Armstrong V.J., Muzylak M.M., Sunters A., et al. Wnt/β-Catenin signaling is a component of osteoblastic bone cells early responses to load-bearing and requires estrogen receptor α. Journal of Biological Chemistry 2007, 13:20715-20717.
12. Barrallo-Gimeno A., Nieto M.A. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 2005, 132:3151-3161.
13. Huppi K., Martin S.E., Caplen N.J. Defining and assaying RNAi in mammalian cells. Molecular Cell 2005, 17:1-10.
14. Valencia-Sanchez M.A., Liu J., Hannon G.J., et al. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes and Development 2006, 20:515-524.
15. Tomari Y., Zamore P.D. Perspective: machines for RNAi. Genes and Development 2005, 19:517-529.
16. Tang N., Song W.X., Luo J., et al. Osteosarcoma development and stem cell differentiation. Clinical Orthopaedics and Related Research 2008, 466:2114-2130.
17. Haydon R.C., Luu H.H., He T.C. Osteosarcoma and osteoblastic differentiation: a new perspective on oncogenesis. Clinical Orthopaedics and Related Research 2007, 454:237-246.
18. Chun .R., de Lorimier L.P. Update on the biology and management of canine osteosarcoma. Veterinary Clinics of North America: Small Animal Practice 2003, 33:491-516.
19. Selvarajah G.T., Kirpensteijn J., van Wolferen M.E., et al. Gene expression profiling of canine osteosarcoma reveals genes associated with short and long survival times. Molecular Cancer 2009, 8:72.
20. O'Day K., Gorlick R. Novel therapeutic agents for osteosarcoma. Expert Review of Anticancer Therapy 2009, 9:511-523.
21. Broadhead M.L., Clark J.C., Myers D.E., et al. The molecular pathogenesis of osteosarcoma: a review. Sarcoma 2011, 2011:959248.
22. Tan M.L., Choong P.F., Dass C.R. Osteosarcoma: conventional treatment vs. gene therapy. Cancer Biology and Therapy 2009, 8:106-117.
23. Mueller F., Fuchs B., Kaser-Hotz B. Comparative biology of human and canine osteosarcoma. Anticancer Research 2007, 27:155-164.
24. Shih J.Y., Tsai M.F., Chang T.H., et al. Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma. Clinical Cancer Research 2005, 11:8070-8078.
25. Joseph M.J., Dangi-Garimella S., Shields M.A., et al. Slug is a downstream mediator of transforming growth factor-beta1-induced matrix metalloproteinase-9 expression and invasion of oral cancer cells. Journal of Cellular Biochemistry 2009, 108:726-736.
26. Zhang K., Chen D., Jiao X., et al. Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling. Laboratory Investigation 2011, 91:426-438.
27. Savagner P., Yamada K.M., Thiery J.P. The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. Journal of Cell Biology 1997, 137:1403-1419.
28. Berx G., van Roy F. Involvement of members of the cadherin superfamily in cancer. Cold Spring Harbour Perspectives Biological 2009, 1:a003129.
29. Kashima T., Kawaguchi J., Takeshita S., et al. Anomalous cadherin expression in osteosarcoma. Possible relationships to metastasis and morphogenesis. American Journal of Pathology 1999, 155:1549-1555.
30. Kashima T., Nakamura K., Kawaguchi J., et al. Overexpression of cadherins suppresses pulmonary metastasis of osteosarcoma in vivo. International Journal of Cancer 2003, 104:147-154.
31. Nakajima G., Patino-Garcia A., Bruheim S., et al. CDH11 expression is associated with survival in patients with osteosarcoma. Cancer Genomics and Proteomics 2008, 5:37-42.
32. Weeraratna A.T., Jiang Y., Hostetter G., et al. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 2002, 1:279-288.
33. Enomoto M., Hayakawa S., Itsukushima S., et al. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling. Oncogone 2009, 28:3197-3208.
34. Ren D., Minami Y., Nishita M. Critical role of Wnt5a-Ror2 signaling in motility and invasiveness of carcinoma cells following Snail-mediated epithelial-mesenchymal transition. Genes to Cells 2011, 16:304-315.
35. Kurayoshi M., Oue N., Yamamoto H., et al. Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Research 2006, 66:10439-10448.
36. Shields M.A., Krantz S.B., Bentrem D.J., et al. Interplay between β1-integrin and Rho signaling regulates differential scattering and motility of pancreatic cancer cells by Slug protein. Journal of Biological Chemistry 2012, 24:6218-6229.
37. Ridley A.J. Life at the leading edge. Cell 2011, 145:1012-1022.
38. Li S., Guan J.L., Chien S. Biochemistry and biomechanics of cell motility. Annual Review of Biomedical Engineering 2005, 7:105-150.
39. Azuma K., Tanaka M., Uekita T., et al. Tyrosine phosphorylation of paxillin affects the metastatic potential of human osteosarcoma. Oncogene 2005, 24:4754-4764.
40. Hagel M., George E.L., Kim A., et al. The adaptor protein paxillin is essential for normal development in the mouse and is a critical transducer of fibronectin signaling. Molecular and Cellular Biology 2002, 22:901-915.
41. Kawano Y., Kypta R. Secreted antagonists of the Wnt signalling pathway. Journal of Cell Science 2003, 116:2627-2634.
42. Chung M.T., Lai H.C., Sytwu H.K., et al. SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway. Gynecologic Oncology 2009, 112:646-653.
43. Bagley R.G. The Tumor Microenvironment 2010, Springer, New York.